Team

Board

Luis Claudio Garcia de Souza

Co-Founder and Chairman

Luis Claudio Garcia de Souza

Co-Founder and Chairman

Civil Engineering from PUC-Rio, Master's in Systems and Transportation Engineering, MIT. Founder and Chairman of Finvest, Chairman of Captalys. Founded and built RB Capital, Rio Bravo Investimentos and UBF Seguros. Executive Committee of Banco Pactual, Board Member, BOVESPA. Advisory Board of Securitas Capital, PE arm of Swiss Re

Martha Farmer, PhD

Board member and Chairman Advisory Board

Martha Farmer, PhD

Board member and Chairman Advisory Board

Co-Founder and CEO (retired) of North Shore InnoVentures, a biotech/cleantech incubator in Boston that has fostered 60 startups. Previously with Baxter Healthcare, Hemoglobin Therapeutics division. Dr. Farmer serves on several company and non-profit boards and is a member of e-Coast Angels. BSc and PhD from Duke University, postdoc at Johns Hopkins, and a Medical Ethics Fellow at Harvard University. 30 publications and 3 patents.

Adriana Machado

Advisory Board member

Adriana Machado

Advisory Board member

Political Science from UnB and an outspoken advocate of the impact economy. Founder of the Briyah Institute, Miami. Mrs. Machado serves on several boards, and is a strategic partner at WOMB Group. First woman President & CEO of GE Brazil, Government Affairs & Policy for GE Latin America. Intel Brazil, Amcham-SP, and US Embassy in Brasilia.

Shawn G. Bengtson, RQAP-GLP

Quality Assurance Advisor

Shawn G. Bengtson, RQAP-GLP

Quality Assurance Advisor

Director of Quality Assurance, Quality Systems Management and Research Operations Management at the University of Pittsburgh. Former National Aeronautics Space Administration (NASA) Life Sciences Division.

Management

Matias Vidal

Co-Founder and CEO

Matias Vidal

Co-Founder and CEO

Bsc. In Economics, Universidad Católica Argentina. Partner, Finvest Group, oversees investments in Biotech and Healthcare through Securitas Biosciences Group, a venture building fund. Mr. Vidal led the formation and organization of Securitas Biosciences and attracted key human resources; a diverse interdisciplinary group of scientists, doctors and executives. In 2013, co-founded Finvest’s group first initiative in the biotech sector, VirTech Bio, and led the company as CEO until August 2019. He is acting CEO of Vaxinz, a biotech start-up that specializes in the design and development of novel vaccines targeting human emerging infectious diseases. He serves as Board member and Executive Chairman of several portfolio companies, VirTech Bio, TheraVax, Meton, OCC Biotech and HZ4 Liver. He has an extensive international career, with over 25 years experience in consulting, Investment Banking, M&A, and portfolio management. Former Cooper&Lybrand, Deutsche Morgan Grenfell, Dresdner Kleinwort Wasserstein

Julián Maggini, MD, PhD

Scientific Advisor

Julián Maggini, MD, PhD

Scientific Advisor

Juián Maggini is an MD PhD from the University of Buenos Aires, Argentina. Dr. Maggini has specialized in internal medicine at the Austral University Hospital and completed his doctoral thesis at the National Academy of Medicine studying the immunological role of mesenchymal stem cells. He has collaborated in the foundation of the cell culture platform in the Department of Pharmacology of the Faculty of Medicine, University of Buenos Aires. He participated in the creation of the General Direction of Science and Technology Policy Management in the City of Buenos Aires, as an advisor to the General Director. He also worked as Medical Director of the Laboratorio Internacional Argentino and Abbott EPD. Since 2015, Dr. Maggini is the Director of the Technology Transfer Office of the Austral University, which articulates the University, the University Hospital and the Austral Technology Business Park - based companies to promote scientific projects of high impact. The strategy of the TTO is to develop demand-oriented Science & Technology platforms, working collaboratively with technology-based companies as strategic partners. We aim to achieve the sustainability of our R&D portfolio and create an innovation ecosystem based on scientific knowledge.

Augusto Carvalho

Chief Financial Officer

Augusto Carvalho

Chief Financial Officer

Senior Analyst at Finvest, responsible for leading the market analysis and the identification of investment opportunities. Responsible for developing a platform thesis for regional healthcare networks (encompassing hospitals, specialized clinics and adjacent business opportunities) in Brazil as well as monitoring and providing management support to portfolio companies. Augusto holds a M.Sc. in Economics from Sao Paulo School of Economics (FGV), B.S. in Economics from the same institution and a B.S. in Physics from USP.

Filipe Vasconcelos

Finance Analyst

Filipe Vasconcelos

Finance Analyst

Senior Analyst at Finvest, specializing in financial analysis and budget forecasting. Leads competitive and market analysis to monitor industry trends and assess competitors. Brings extensive experience in Brazil's public sector, spanning both executive and legislative branches. Holds a Master’s degree in Economics from the University of São Paulo (USP) and a Bachelor’s degree in Economics from the Federal University of Pernambuco (UFPE).

Federico Asis

Internal Legal Counsel

Federico Asis

Internal Legal Counsel

Lawyer with extensive experience in advising companies, organizational restructuring, legal support for HR departments, and litigation management. Graduated from UBA with a specialization in labor law, with experience working in medium and large-scale law firms, providing counsel on contract drafting and negotiation, regulatory compliance, dispute resolution, and labor relations.